Enrichment of Exosomes (EV) with TFF and SEC
We demonstrate a scalable workflow for the isolation of exosomes— a type of extracellular vesicle with significant potential for targeted drug/gene delivery.
Exosomes are extracellular vesicles being investigated for use as biomarkers, drug delivery vehicles, cancer vaccines, and cell-free therapies. Exosome manufacturing processes, including exosome purification, must be compatible with good manufacturing practices (GMP) environments when generating clinical material.
Use our know-how to simplify and accelerate your development and meet your process milestones.